-
Mashup Score: 0
STAT’s latest report dives into new GLP-1-based obesity drugs like Ozempic and Wegovy and explores their impact on science, business, health care, and society. The obesity revolution has commenced, but its implications are just unfolding. Explore the surprising and sometimes fractious science behind the drugs.
Source: reports.statnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1STAT Reports - 9 month(s) ago
STAT Reports help you make sense of the ever-changing life sciences industry — and stay abreast of the latest companies, disruptive technologies, and personalities shaping the space.
Source: reports.statnews.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 4
STAT’s latest report dives into new GLP-1-based obesity drugs like Ozempic and Wegovy and explores their impact on science, business, health care, and society. The obesity revolution has commenced, but its implications are just unfolding. Explore the surprising and sometimes fractious science behind the drugs.
Source: reports.statnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 2STAT Reports - 9 month(s) ago
STAT Reports help you make sense of the ever-changing life sciences industry — and stay abreast of the latest companies, disruptive technologies, and personalities shaping the space.
Source: reports.statnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 8
STAT’s latest report dives into new GLP-1-based obesity drugs like Ozempic and Wegovy and explores their impact on science, business, health care, and society. The obesity revolution has commenced, but its implications are just unfolding. Explore the surprising and sometimes fractious science behind the drugs.
Source: reports.statnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0STAT Reports - 10 month(s) ago
STAT Reports help you make sense of the ever-changing life sciences industry — and stay abreast of the latest companies, disruptive technologies, and personalities shaping the space.
Source: reports.statnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 2Clinical trial subgroup analysis: How to evaluate post hoc tests for significance in failed clinical trials - 12 month(s) ago
In this report, author Frank David, M.D., Ph.D., explores the three key reasons to be skeptical when interpreting findings from post hoc subgroup analyses, drawing from real-world examples of biotech companies that succeeded or failed. This guide emphasizes a data-centric evaluation valuable to investors, researchers, patients, and others.
Source: reports.statnews.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 72023 Update: STAT’s guide to interpreting clinical trial results - 1 year(s) ago
There is an art to reading, and writing, scientific results – and you can learn it. STAT’s bestselling report is now updated to provide the tools to help you read clinical trial results with an appropriately skeptical (or critical) eye. This report gives you the foundation you need to make smarter business decisions.
Source: reports.statnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 72023 Update: STAT’s guide to interpreting clinical trial results - 1 year(s) ago
There is an art to reading, and writing, scientific results – and you can learn it. STAT’s bestselling report is now updated to provide the tools to help you read clinical trial results with an appropriately skeptical (or critical) eye. This report gives you the foundation you need to make smarter business decisions.
Source: reports.statnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 22023 Update: STAT’s guide to interpreting clinical trial results - 1 year(s) ago
There is an art to reading, and writing, scientific results – and you can learn it. STAT’s bestselling report is now updated to provide the tools to help you read clinical trial results with an appropriately skeptical (or critical) eye. This report gives you the foundation you need to make smarter business decisions.
Source: reports.statnews.comCategories: General Medicine News, General HCPsTweet
STAT's latest report gathers articles from the #ObesityRevolution series to guide you through the rapidly evolving business landscape for obesity medications. Get it here: https://t.co/cHKWS6IBKm #STATReports https://t.co/JZaxPZniP7